Skip to main content

Advisors Preferred, LLC

SEC CIK
0001598841
Latest filing
Aug 11, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Advisors Preferred, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
31,074
Value
$5.41M
% of portfolio
0.8%
Quarters held
2
Since Q4 2025
Holdings of NBIX by Advisors Preferred, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202631,074$5.41M0.8%+31,074NewHolders
Q1 20260$00.0%−29,867−100.0%Sold outHolders
Q4 202529,867$4.20M0.7%+29,867NewHolders